A Prospective, Randomized, Open-label Clinical Trial to Evaluate the Effect of Tektura (Aliskiren), Angiotensin Inhibitors, Diuretics, and Calcium Channel Blockers on Coronary Flow Reserve in Patients With Type II Diabetes and Hypertension.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Aliskiren; Amlodipine; Hydrochlorothiazide; Lisinopril
- Indications Hypertension
- Focus Therapeutic Use
- 27 Sep 2017 Status changed from discontinued to withdrawn prior to enrolment.
- 27 Sep 2017 Planned End Date changed from 1 Oct 2012 to 1 Dec 2012.
- 10 Jun 2017 Biomarkers information updated